Core Insights - Treace Medical Concepts, Inc. is set to release its financial results for Q2 2025 on August 7, 2025, after market close, followed by a conference call at 4:30 pm ET to discuss the results [1] - The company specializes in medical technology aimed at improving surgical treatments for bunions and midfoot deformities, with innovative procedures like Lapiplasty and Adductoplasty [1][4] Company Overview - Treace Medical Concepts focuses on advancing surgical management standards for bunions, which affect approximately 67 million Americans, with an estimated 1.1 million being surgical candidates annually [4] - The company has developed the patented Lapiplasty® 3D Bunion Correction® System, which addresses the root cause of bunions by correcting deformities in three planes and stabilizing the affected joint [4] - Additional products include the Adductoplasty® Midfoot Correction System, SpeedMTP™ Rapid Compression Implant, and systems for minimally invasive surgeries, expanding Treace's presence in the foot and ankle market [4]